The risk of reactivation of or new infection with C. neoformans is likely to be related to the duration of severe immunosuppression; current patients with a CD4 cell count <100 cells/μL in South Africa may not have been at this level of immunosuppression for as long as patients in prior years due to improvements in ART provision and access [23]. The gene discussed is CD4; the disease is infection.